BILL · 2017–18 SESSION

SB 5626: Step therapy/stage 4 cancer

Prohibiting the use of step therapy in treatments for stage four advanced, metastatic cancer.

Summary

  • Prohibits the use of step therapy in the treatment of metastatic cancer.

From the Senate Bill Report (Orig.) (SB 5626), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedFeb 1, 2017
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Mark Miloscia (R-30)
Introduced
February 1, 2017 in the Senate
Last action
January 8, 2018
Budget
Has a fiscal note

AN ACT Relating to prohibiting the use of step therapy in treatments for stage four advanced, metastatic cancer;

Sponsors

Prime sponsor: Mark Miloscia (R-30)

2 co-sponsors (1 Democrat, 1 Republican)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. Due to Senate committee reorganization, referred to Health & Long Term Care.
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status.
  4. By resolution, reintroduced and retained in present status.
  5. By resolution, reintroduced and retained in present status.
  6. First reading, referred to Health Care.

SB 5626 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page